GENE ONLINE|News &
Opinion
Blog

Amgen
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Aug 28-Sept 1
2023-09-05
Policy LawsuitAmgen
Amgen Faces Class Action Lawsuit for Concealing $10.7 Billion Tax Bill to Manipulate Stock Price
2023-03-16
Trials & Approvals Biosimilar
Amgen’s Humira Biosimilar Now Available in the U.S.
2023-02-01
Asia-Pacific Antibody-Drug Conjugate
Following Amgen, Hummingbird Jumps Onto Synaffix’s ADC Platform In $150 Million Licensing Deal
2023-01-06
Special biopharma
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
M&A Amgen
Amgen Leads the Pack After Sanofi Drops Out of Horizon Bid
2022-12-11
Policy Lawsuit
Supreme Court Rejects Juno, Welcomes Amgen Back to Patent Discussions
2022-11-08
Partnerships acquisitionAnti-inflammatory Drugs
Amgen Lays Down $3.7 Billion For ChemoCentryx and its Autoimmune Portfolio
2022-08-04
Licensing China
Amgen Out-Licenses Two Therapies to Fosun Pharma to Expand Presence in China
2022-06-28
Special Iceland
Recounting 25 Years of Genetic and Human Diversity Discovery With deCODE Founder Kari Stefansson
2022-05-26
Funding Targeted Protein Degradation
Plexium Bags $102 Million for Targeted Protein Degraders
2022-02-24
Feature JPM
JPM22 Highlights: Amgen Sees Potential in Arrakis, Freenome Gets Boosted by Roche Again
2022-01-12
Deals AI
Amgen Taps Generate to Discover Multi-Target Protein Drugs in $1.9+ Billion Deal
2022-01-07
Trials & Approvals Migraine
Amgen Announces Encouraging Full Data for Migraine Drug, Aimovig
2021-11-09
Trials & Approvals Atopic Dermatitis
Kyowa Kirin, Amgen’s Atopic Dermatitis Drug Delivers Strong Results in Phase 2 Trial
2021-10-05
1 2 3
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
READ MORE
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top